Celemics, Inc. (KOSDAQ:331920)
10,070
+260 (2.65%)
At close: Oct 21, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 112.6 billion as of October 21, 2026. It is the 26,335th most valuable company in the world and the 1,187th biggest in South Korea. Its market cap has increased by 350.71% in one year.
Market Cap
112.60B
Enterprise Value
90.70B
Revenue
5.22B
Global Rank
Country Rank
#1,187 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 112.60B, a decrease of -43.79%. That is a compound annual growth rate of -8.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 112.60B | 407.99% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biodyne | 180.99B |
| BIOBIJOU | 180.29B |
| M.I.TECH Co.,Ltd | 151.31B |
| Synergy Innovation | 128.81B |
| RecensMedical | 72.60B |
| Corentec | 69.99B |
| DENTIS CO.,Ltd | 39.21B |
| Finemedix | 32.69B |